Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area
Alimentary Pharmacology and Therapeutics Apr 10, 2018
Kim HY, et al. - The effectiveness of hepatocellular carcinoma (HCC) surveillance was inspected in a hepatitis B-endemic area among patients who were newly diagnosed with HCC between 2005 and 2012 at a single tertiary hospital in Korea. The most common aetiology was found to be hepatitis B, with cirrhosis being present in 78.2%. Compared to the irregular surveillance or nonsurveillance groups, subjects in the regular surveillance group were diagnosed at earlier stages and had a greater chance for curative treatments than the irregular surveillance or nonsurveillance group. A link was brought to light between HCC surveillance with longer survival due to the earlier diagnosis and curative treatment. Findings illustrated that the survival advantage was vital with regular surveillance but not with irregular surveillance.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries